Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (241-250 of 384) with videos related to

Pageof 39
Sort By:
Thrombosis Research|June 1, 1989
Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparinC Doutremepuich, E Deharo, M Guyot, et al.
The Medical Clinics of North America|July 1, 1998
Antithrombin agents as anticoagulants and antithrombotics. Implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 26, 2003
In vitro simulation of therapeutic plasmatic fibrinolysisT W Stief, R Bünder, A Richter, et al.
American Journal of Hematology|September 1, 1988
Neonatal and maternal platelets: activation at time of birthC R Suarez, J Gonzalez, C Menendez, et al.
Haemostasis|January 1, 1991
Laboratory assays for the evaluation of recombinant hirudinJ M Walenga, D Hoppensteadt, M Koza, et al.
Clinical Chemistry|August 14, 1998
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromesJ Fareed, D A Hoppensteadt, F Leya, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
Ecarin clotting time is sensitive to heparinoids: comparison of two different techniquesM Demir, O Iqbal, B Untch, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
A comparison of the pharmacokinetic and pharmacodynamic profiles of Clexane and Lovenox in dogsO Iqbal, W Jeske, P Bacher, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1984
Antithrombotic actions and pharmacokinetics of heparin fractions and fragmentsJ Fareed, A Kumar, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Impact of automation on the quantitation of low molecular weight markers of hemostatic defectsJ Fareed, J M Walenga, R L Bick, et al.
Pageof 39

Showing results (241-250 of 384) with videos related to

Sort By:
Pageof 39
Thrombosis Research|June 1, 1989
Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparinC Doutremepuich, E Deharo, M Guyot, et al.
The Medical Clinics of North America|July 1, 1998
Antithrombin agents as anticoagulants and antithrombotics. Implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 26, 2003
In vitro simulation of therapeutic plasmatic fibrinolysisT W Stief, R Bünder, A Richter, et al.
American Journal of Hematology|September 1, 1988
Neonatal and maternal platelets: activation at time of birthC R Suarez, J Gonzalez, C Menendez, et al.
Haemostasis|January 1, 1991
Laboratory assays for the evaluation of recombinant hirudinJ M Walenga, D Hoppensteadt, M Koza, et al.
Clinical Chemistry|August 14, 1998
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromesJ Fareed, D A Hoppensteadt, F Leya, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
Ecarin clotting time is sensitive to heparinoids: comparison of two different techniquesM Demir, O Iqbal, B Untch, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
A comparison of the pharmacokinetic and pharmacodynamic profiles of Clexane and Lovenox in dogsO Iqbal, W Jeske, P Bacher, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1984
Antithrombotic actions and pharmacokinetics of heparin fractions and fragmentsJ Fareed, A Kumar, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Impact of automation on the quantitation of low molecular weight markers of hemostatic defectsJ Fareed, J M Walenga, R L Bick, et al.
Pageof 39